Technical Analysis for GBT - Global Blood Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
GBT closed up 0.32 percent on Friday, February 23, 2018, on 44 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
|See historical GBT trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 23||Hammer Candlestick||Bullish||0.00%|
|Feb 23||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.00%|
|Feb 23||Wide Bands||Range Expansion||0.00%|
|Feb 22||Upper Bollinger Band Walk||Strength||0.32%|
|Feb 22||Inside Day||Range Contraction||0.32%|
|Feb 22||Wide Bands||Range Expansion||0.32%|
|Feb 21||Bearish Engulfing||Bearish||2.20%|
|Feb 21||Slingshot Bullish||Bullish Swing Setup||2.20%|
|Feb 21||New 52 Week High||Strength||2.20%|
|Feb 21||Outside Day||Range Expansion||2.20%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more GBT news...
|52 Week High||68.05|
|52 Week Low||24.02|
|200-Day Moving Average||36.4264|
|50-Day Moving Average||51.7225|
|20-Day Moving Average||60.8588|
|10-Day Moving Average||61.925|
|Average True Range||3.7483|
|Chandelier Exit (Long, 3 ATRs )||56.8051|
|Chandelier Exit (Short, 3 ATRs )||64.2449|
|Upper Bollinger Band||65.3446|
|Lower Bollinger Band||56.373|
|Percent B (%b)||0.72|
|MACD Signal Line||3.2251|
|Market Cap||2.74 Billion|
|Num Shares||43.7 Million|
|Price-to-Earnings (P/E) Ratio||-25.55|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||66.18|
|Resistance 3 (R3)||66.06||64.83||65.63|
|Resistance 2 (R2)||64.83||63.98||64.89||65.44|
|Resistance 1 (R1)||63.84||63.46||63.23||63.96||65.25|
|Support 1 (S1)||61.62||61.76||61.01||61.74||60.45|
|Support 2 (S2)||60.39||61.24||60.45||60.26|
|Support 3 (S3)||59.40||60.39||60.08|
|Support 4 (S4)||59.52|